Neurological manifestations in severe acute respiratory syndrome

Acta Neurologica Taiwanica

Volumn 14, Issue 3, 2005, Pages 113-119

  Tsai, Li Kai ^a   Hsieh, Sung Tsang ^a,b   Chang, Yang Chyuan ^a,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c MIN SHENG GENERAL HOSPITAL   (Taiwan)

Author keywords

Cerebral infarct; Coronavirus; Myopathy; Polyneuropathy; SARS

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE;

BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CRITICAL ILLNESS; DISEASE ASSOCIATION; DRUG MEGADOSE; ELECTROPHYSIOLOGY; FOLLOW UP; HUMAN; HYPERCOAGULABILITY; MICROBIAL ACTIVITY; MYOPATHY; POLYNEUROPATHY; PROGNOSIS; PULSATILE DRUG RELEASE; REVIEW; RHABDOMYOLYSIS; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

CEREBRAL INFARCTION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; POLYNEUROPATHIES; RHABDOMYOLYSIS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 26244435815     PISSN: 10196099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Summary table of SARS cases by country, 1 November 2002-7 August 2003. Geneva: World Health Organization, 2003. (Accessed Sep 4, 2003, at http://www.who.int/csr/ sars/country/.)
2. Taiwan SARS case update. Taiwan: Center for Disease Control, 2003. (Accessed Sep 4, 2003, at http://www.cdc. gov.tw/sarsen/.)
3. Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348:1986-94.
4. Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348:1977-85.
5. Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003;348:1995-2005.
6. So LK, Lau AC, Yam LY, et al. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 2003;361:1615-7.
7. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953-66.
8. Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-76.
9. Rota PA, Oberste MS, Monroe SS, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003;300:1394-9.
10. Lai MMC, Holmes KV. Coronaviridae: the viruses and their replication. Fundamental Virology. Philadelphia: Lippicott Williams & Wilkins press, 2001:641-63.
11. Foley JE, Leutenegger C. A review of coronavirus infection in the central nervous system of cats and mice. J Vet Intern Med 2001;15:438-44.
12. Umapathi T, Kor AC, Venketasubramanian N, et al. Large artery ischaemic stroke in severe acute respiratory syndrome (SARS). J Neurol 2004;251:1227-31.
13. Tsai LK, Hsieh ST, Chao CC, et al. Neuromuscular disorders in severe acute respiratory syndrome. Arch Neurol 2004;61:1669-73.
14. Chao CC, Tsai LK, Chiou YH, et al. Peripheral nerve disease in SARS: report of a case. Neurology 2003;61:1820-1.
15. Wang JL, Wang JT, Yu CJ, et al. Rhabdomyolysis associated with probable SARS. Am J Med 2003;115:421-2.
16. Witt NJ, Zochodne DW, Bolton CF, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991; 99:176-84.
17. Hund E. Critical illness polyneuropathy. Curr Opin Neurol 2001;14:649-53.
18. Hund E. Neurological complications of sepsis: critical illness polyneuropathy and myopathy. J Neurol 2001;248:929-34.
19. Gutmann L, Gutmann L. Critical illness neuropathy and myopathy. Arch Neurol 1999;56:527-8.
20. Bolton CF, Breuer AC. Critical illness polyneuropathy. Muscle Nerve 1999;22:419-24.
21. Bolton CF, Young GB, Zochodne DW. The neurological complications of sepsis. Ann Neurol 1993;33:94-100.
22. Zochodne DW, Bolton CF, Wells GA, et al. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 1987;110:819-41.
23. Solbrig MV. Infections of the nervous system. Neurology in Clinical Practice. USA. Butterworth-Heinemann press, 2000:1315-430.
24. Fox RJ, Galetta SL, Mahalingam R, et al. Acute, chronic, and recurrent varicella zoster virus neuropathy without zoster rash. Neurology 2001;57:351-4.
25. Kolson DL, Gonzalez-Scarano F. HIV-associated neuropathies: role of HIV-1, CMV, and other viruses. J Peripher Nerv Syst 2001;6:2-7.
26. Wulff EA, Wang AK, Simpson DM. HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. Drugs 2000;59:1251-60.
27. Mahadevan A, Gayathri N, Taly AB, et al. Vasculitic neuropathy in HIV infection: a clinicopathological study. Neurol India 2001;49:277-83.
28. Engel WK. Intravenous immunoglobulin G is remarkably beneficial in chronic immune dysschwannian/dysneuronal polyneuropathy, diabetes-2 neuropathy, and potentially in severe acute respiratory syndrome. Acta Myol 2003;22:97-103.
29. Agyeman P, Duppenthaler A, Heininger U, et al. Influenza-associated myositis in children. Infection 2004;32:199-203.
30. McDonagh CA, Holman RP. Primary human immunodeficiency virus type 1 infection in a patient with acute rhabdomyolysis. South Med J 2003;96:1027-30.
31. Marinella MA. Exertional rhabdomyolysis after recent cox-sackie B virus infection. South Med J 1998;91:1057-9.
32. Hughes GS Jr, Hunt R. Cytomegalovirus infection with rhabdomyolysis and myoglobinuria. Ann Intern Med 1984; 101:276-7.
33. Medarov B, Multz AS, Brown W, et al. West Nile meningoencephalitis and rhabdomyolysis. Lancet Infect Dis 2005;5:2.
34. Davis JS, Bourke P. Rhabdomyolysis associated with dengue virus infection. Clin Infect Dis 2004;38:e109-11.
35. Lew TW, Kwek TK, Tai D, et al. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA 2003;290:374-80.
36. Chong PY, Chui P, Ling AE, et al. Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore. Arch Pathol Lab Med 2004;128:195-204.
37. Lang Z, Zhang L, Zhang S, et al. Pathological study on severe acute respiratory syndrome. Chin Med J 2003;116: 976-80.
38. Chen J, Zhang HT, Xie YQ, et al. Morphological study of severe acute respiratory syndrome (SARS). Chung-hua Ping Li Hsueh Tsa Chih 2003;32:516-20. (In Chinese)
39. Ding Y, Wang H, Shen H, et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol 2003;200:282-9.
40. Shen YM, Frenkel EP. Thrombosis and a hypercoagulable state in HIV-infected patients. Clin Appl Thromb Hemost 2004;10:277-80.
41. Key NS, Vercellotti GM, Winkelmann JC, et al. Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc Natl Acad Sci U S A 1990;87:7095-9.
42. Rahbar A, Soderberg-Naucler C. Human cytomegalovirus infection of endothelial cells triggers platelet adhesion and aggregation. J Virol 2005;79:2211-20.
43. Hal SV, Senanayake S, Hardiman R. Splenic infarction due to transient antiphospholipid antibodies induced by acute Epstein-Barr virus infection. J Clin Virol 2005;32:245-7.
44. Chen WH, Kao YF, Liu JS. An increase of blood anti-beta2-glycoprotein I antibody in Japanese encephalitis associated with cerebral ischemia. Blood Coagul Fibrinolysis 2005;16:55-9.
45. Visser MR, Tracy PB, Vercellotti GM, et al. Enhanced thrombin generation and platelet binding on herpes simplex virus-infected endothelium. Proc Natl Acad Sci U S A 1988;85:8227-30.
46. So LK, Lau AC, Yam LY, et al. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 2003;361:1615-7.
47. Vucic S, Chong PS, Dawson KT, et al. Thromboembolic complications of intravenous immunoglobulin treatment. Eur Neurol 2004;52:141-4.
48. Caress JB, Cartwright MS, Donofrio PD, et al. The clinical features of 16 cases of stroke associated with administration of IVIg. Neurology 2003;60:1822-4.
49. Dalakas MC, Clark WM. Strokes, thromboembolic events, and IVIg: rare incidents blemish an excellent safety record. Neurology 2003;60:1736-7.
50. Okuda D, Flaster M, Frey J, et al. Arterial thrombosis induced by IVIg and its treatment with tPA. Neurology 2003;60:1825-6.
51. Zaidan R, Al Moallem M, Wani BA, et al. Thrombosis complicating high dose intravenous immunoglobulin: report of three cases and review of the literature. Eur J Neurol 2003;10:367-72.
52. Feuillet L, Guedj E, Laksiri N, et al. Deep vein thrombosis after intravenous immunoglobulins associated with methylprednisolone. Thromb Haemost 2004;92:662-5.
53. Kleinschmidt-DeMasters BK, Gilden DH. Varicella-zoster virus infections of the nervous system: clinical and pathologic correlates. Arch Pathol Lab Med 2001;125:770-80.
54. Nogueras C, Sala M, Sasal M, et al. Recurrent stroke as a manifestation of primary angiitis of the central nervous system in a patient infected with human immunodeficiency virus. Arch Neurol 2002;59:468-73.
55. Khella SL, Souayah N. Hepatitis C: a review of its neurologic complications. Neurologist 2002;8:101-6.
56. Zochodne DW. SARS, SIRS, and neurological disease. Arch Neurol 2004;61:1647-8.